Loading...

VNRX VOLITIONRX LTD Earnings Reports 8-K Filing

VLTN

VNRX

VOLITIONRX LTD

(VNRX)

2025 8-K

Management Change

Financial Results Update

Amended Underwriting Agreement

Offering Amendment

Stock Offering Update

Public Offering Details

Financial Results Announcement

Equity Offerings

Increase in authorized shares

Financial Statements

Share Sale Agreement

Stock Registration

Financial Results

Management Appointment

Director Appointment

Management Changes

Oncology Portfolio

Financial Results

Annual Meeting Approval and...

Earnings Reports

Financial Results and Busin...

Financing Round

Amendment to Stock Incentiv...

Agreement for Public Offering

External Links:

On November 13, 2025, VolitionRx Limited announced its financial results for the quarter ending September 30, 2025, and confirmed a conference call for November 14, 2025, at 8:30 a.m. ET.

AI Assistant

VOLITIONRX LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.